{
  "docId": "019de074-2806-77f1-979f-2c5838bae35a",
  "docSlug": "7e995254b839b7fbb7e998df4127a7b8",
  "documentTitle": "ATAI | Investor Presentation Deck | 33 slides",
  "authorId": "atai",
  "authorName": "atai Life Sciences",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-01-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 18,
  "pageCount": 33,
  "prevPage": 17,
  "nextPage": 19,
  "slideType": "executive_summary",
  "function": "summarize",
  "density": "dense",
  "nDataPoints": 8,
  "notes": "The slide uses a split layout: a left-hand sidebar for product summary and a right-hand side for clinical data visualization.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de074-2806-77f1-979f-2c5838bae35a/18",
  "deckHref": "/decks/019de074-2806-77f1-979f-2c5838bae35a",
  "deckJsonHref": "/decks/019de074-2806-77f1-979f-2c5838bae35a.json",
  "deckAnchorHref": "/decks/019de074-2806-77f1-979f-2c5838bae35a#slide-18",
  "components": [
    {
      "bbox": {
        "h": 0.6,
        "w": 0.6,
        "x": 0.37,
        "y": 0.25
      },
      "kind": "chart",
      "text": "Double-blind, randomized placebo-controlled trial with Ayahuasca in 29 patients with TRD",
      "attrs": null,
      "subkind": "line",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "0d92c8c6-3b0f-4d0e-80ec-2ff5825fd826",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.7,
        "w": 0.3,
        "x": 0.05,
        "y": 0.15
      },
      "kind": "list",
      "text": "OWNERSHIP: 100% | PRODUCT: VLS-01 (DMT) | PHARMACOLOGY: 5-HT2A-R agonist | FEATURES: Rapid onset, short duration | INDICATIONS: TRD, Eating Disorders, SUD | STATUS: Phase 1 | IP: Filed provisionals | HIGHLIGHT: Improved duration/tolerability",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "9c6f014a-3b70-4c3c-8708-69a479dccba6",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.6,
        "x": 0.37,
        "y": 0.9
      },
      "kind": "source-note",
      "text": "Note: MADRS = Montgomery-Asberg Depression Rate Scale, DMT = Dimethyltryptamine. 1. Ownership... 2. Palhano-Fontes et al.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "036086e1-25c4-495d-9c86-28367b482f02",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.6,
        "x": 0.37,
        "y": 0.08
      },
      "kind": "title",
      "text": "VLS-01 may increase patient accessibility by reducing patient and clinic time commitment",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ace94d69-1eea-497f-a69d-f3f43a7e7b43",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.15,
        "x": 0.05,
        "y": 0.08
      },
      "kind": "title",
      "text": "SUMMARY",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b0e37e97-2151-4faa-a8e0-5d7dcabb4aa8",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Audience Definition",
      "slug": "audience-definition",
      "agent": "Storyteller",
      "layer": "slide",
      "matchId": "85334be7-6dea-4eea-afa6-d8f152bc2dc3",
      "evidence": "The slide components mention specific details about the product, pharmacology, and indications, suggesting that the audience is likely medical professionals or investors.",
      "confidence": 0.7
    },
    {
      "name": "Executive summary",
      "slug": "executive-summary",
      "agent": null,
      "layer": "slide",
      "matchId": "e5a70861-2509-4758-b734-46c7740b23f6",
      "evidence": "The slide title is 'VLS-01 may increase patient accessibility by reducing patient and clinic time commitment' and type is 'executive_summary'.",
      "confidence": 0.9
    }
  ],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}